|
ZNF235 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.70734562441066E-14 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.0060619831952E-12 |
| Normal-vs-Stage2 |
1.6344003928026E-10 |
| Normal-vs-Stage3 |
1.62525548574877E-12 |
| Normal-vs-Stage4 |
1.62669877568078E-12 |
| Stage1-vs-Stage2 |
6.786200E-01 |
| Stage1-vs-Stage3 |
6.097700E-03 |
| Stage1-vs-Stage4 |
1.395750E-02 |
| Stage2-vs-Stage3 |
2.954200E-02 |
| Stage2-vs-Stage4 |
3.406400E-02 |
| Stage3-vs-Stage4 |
9.969200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.60982338570648E-14 |
| Normal-vs-AfricanAmerican |
1.0821999962829E-08 |
| Normal-vs-Asian |
5.57000001677466E-09 |
| Caucasian-vs-AfricanAmerican |
3.100400E-01 |
| Caucasian-vs-Asian |
4.388000E-02 |
| AfricanAmerican-vs-Asian |
6.693600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.06692432666478E-13 |
| Normal-vs-Female |
1.66733293838206E-12 |
| Male-vs-Female |
9.339400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.81399339993504E-12 |
| Normal-vs-Age(41-60Yrs) |
5.17363929475323E-14 |
| Normal-vs-Age(61-80Yrs) |
1.65423230669148E-14 |
| Normal-vs-Age(81-100Yrs) |
2.303400E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.982000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.800200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.422000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.535800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.721200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.844200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.31300000000023E-05 |
| Classical-VS-Follicular |
9.397800E-01 |
| Classical-VS-Other |
9.468800E-01 |
| Classical-VS-Normal |
3.55515616945468E-12 |
| Tall-VS-Follicular |
9.960600E-04 |
| Tall-VS-Other |
1.936570E-01 |
| Tall-VS-Normal |
1.62447832963153E-12 |
| Follicular-VS-Other |
9.361200E-01 |
| Follicular-VS-Normal |
9.76674296992996E-12 |
| Other-VS-Normal |
1.995640E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.11022302462516E-16 |
| Normal-vs-N1 |
1.88737914186277E-15 |
| N0-vs-N1 |
2.561700E-02 |
|
|
